Fracture healing and biomarker expression in a diabetic Zucker rat model

Journal of the American Podiatric Medical Association

Volumn 104, Issue 5, 2014, Pages 428-433

  La Fontaine, Javier ^a   Hunt, Nathan A ^b   Curry, Stacey ^a   Kearney, Tyler ^c   Jupiter, Daniel ^d   Shibuya, Naohiro ^e   Lavery, Lawrence A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Orthopaedic Spine Center of the Rockies   (United States)

^c Brazos Valley Foot Care   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^e Central Texas VA Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; VASCULOTROPIN A;

ANIMAL; ANIMAL MODEL; BLOOD; EXPERIMENTAL DIABETES MELLITUS; FEMUR; FRACTURE HEALING; FRACTURES, BONE; INJURIES; PHYSIOLOGY; STATISTICAL MODEL; ZUCKER RAT;

ANIMALS; BIOMARKERS; CHEMOKINE CCL3; DIABETES MELLITUS, EXPERIMENTAL; FEMUR; FRACTURE HEALING; FRACTURES, BONE; LOGISTIC MODELS; MODELS, ANIMAL; RATS, ZUCKER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908015111     PISSN: 87507315     EISSN: 19308264     Source Type: Journal    
DOI: 10.7547/0003-0538-104.5.428     Document Type: Article

References (42)

1. MELTON LJ III, LEIBSON CL, ACHENBACH SJ, et al.: Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 23: 1334, 2008.
2. MELTON LJ III, RIGGS BL, LEIBSON CL, et al.: A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab 93: 4804, 2008.
3. SCHWARTZ AV, SELLMEYER DE, ENSRUD KE, et al.: Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86: 32, 2001.
4. LAVERY LA, PETERS EJ, WILLIAMS JR, et al.: Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 31: 154, 2008.
5. WUKICH DK, KLINE AJ: The management of ankle fractures in patients with diabetes. J Bone Joint Surg Am 90: 1570, 2008.
6. PAPA J, MYERSON M, GIRARD P: Salvage, with arthrodesis, in intractable diabetic neuropathic arthropathy of the foot and ankle. J Bone Joint Surg Am 75: 1056, 1993.
7. TISDEL CL, MARCUS RE, HEIPLE KG: Triple arthrodesis for diabetic peritalar neuroarthropathy. Foot Ankle Int 16: 332, 1995.
8. GLOWACKI J: Angiogenesis in fracture repair. Clin Orthop Relat Res 355 (suppl): S82, 1998.
9. BEAMER B, HETTRICH C, LANE J: Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing. HSS J 6: 85, 2010.
10. TSUBAKI M, KATO C, MANNO M, et al.: Macrophage inflammatory protein-1a (MIP-1α) enhances a receptor activator of nuclear factor kB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways. Mol Cell Biochem 304: 53, 2007.
11. CAO JJ: Effects of obesity on bone metabolism. J Orthop Surg Res 6: 30, 2011.
12. ELEFTERIOU F, TAKEDA S, EBIHARA K, et al.: Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A 101: 3258, 2004.
13. BRUSSEE V, GUO G, DONG Y, et al.: Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model. Diabetes 57: 1664, 2008.
14. CALCUTT NA, CHAPLAN SR: Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 122: 1478, 1997.
15. BONNARENS F, EINHORN TA: Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2: 97, 1984.
16. MACEY LR, KANA SM, JINGUSHI S, et al.: Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg Am 71: 722, 1989.
17. GARCIA P, HOLSTEIN JH, HISTING T, et al.: A new technique for internal fixation of femoral fractures in mice: impact of stability on fracture healing. J Biomech 41: 1689, 2008.
18. CLARK JB, PALMER CJ, SHAW WN: The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173: 68, 1983.
19. CHEN D, WANG MW: Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 7: 307, 2005.
20. BEKKER PJ, HOLLOWAY D, NAKANISHI A, et al.: The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16: 348, 2001.
21. BOLANDER ME: Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200: 165, 1992.
22. KAWAGUCHI H, KUROKAWA T, HANADA K, et al.: Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135: 774, 1994.
23. TYNDALL WA, BEAM HA, ZARRO C, et al.: Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clin Orthop Relat Res 408: 319, 2003.
24. BLAKYTNY R, JUDE E: The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 23: 594, 2006.
25. JUDE EB, BLAKYTNY R, BULMER J, et al.: Transforming growth factor-b 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med 19: 440, 2002.
26. WIEMAN TJ; Becaplermin Gel Studies Group: Clinical efficacy of becaplermin (rhPDGF-BB) gel. Am J Surg 176: 74S, 1998.
27. WIEMAN TJ, SMIELL JM, SU Y: Efficacy and safety of a topical gel formulation of recombinant human plateletderived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 21: 822, 1998.
28. BENNETT SP, GRIFFITHS GD, SCHOR AM, et al.: Growth factors in the treatment of diabetic foot ulcers. Br J Surg 90: 133, 2003.
29. TSANG MW, WONG WK, HUNG CS, et al.: Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 26: 1856, 2003.
30. WILDEMANN B, BAMDAD P, HOLMER C, et al.: Local delivery of growth factors from coated titanium plates increases osteotomy healing in rats. Bone 34: 862, 2004.
31. WILDEMANN B, SCHMIDMAIER G, BRENNER N, et al.: Quantification, localization, and expression of IGF-I and TGFb1 during growth factor-stimulated fracture healing. Calcif Tissue Int 74: 388, 2004.
32. WEISS S, ZIMMERMANN G, PUFE T, et al.: The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg 129: 989, 2009.
33. ZIMMERMANN G, HENLE P, KUSSWETTER M, et al.: TGF-b1 as a marker of delayed fracture healing. Bone 36: 779, 2005.
34. ZIMMERMANN G, MOGHADDAM A, REUMANN M, et al.: TGF-b1 as a pathophysiological factor in fracture healing [in German]. Unfallchirurg 110: 130, 2007.
35. GANDHI A, DOUMAS C, O’CONNOR JP, et al.: The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 38: 540, 2006.
36. KUKITA T, NOMIYAMA H, OHMOTO Y, et al.: Macrophage inflammatory protein-1 a (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment. Lab Invest 76: 399, 1997.
37. CHOI SJ, CRUZ JC, CRAIG F, et al.: Macrophage inflammatory protein 1-a is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96: 671, 2000.
38. HAMRICK MW, PENNINGTON C, NEWTON D, et al.: Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34: 376, 2004.
39. VAN DIELEN FM, VAN’T VEER C, SCHOLS AM, et al.: Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 25: 1759, 2001.
40. DIAZ VA, MAINOUS AG III, BAKER R, et al.: How does ethnicity affect the association between obesity and diabetes? Diabet Med 24: 1199, 2007.
41. MAHDY RA, NADA WM, HADHOUD KM, et al.: The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye 24: 1576, 2010.
42. TAVAKKOLY-BAZZAZ J, AMOLI MM, PRAVICA V, et al.: VEGF gene polymorphism association with diabetic neuropathy. Mol Biol Rep 37: 3625, 2010.